Use of angiogenin or angiogenin agonists for treating diseases and disorders
US10456453B2 · kind B2 · utility
0Cited by
10References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 13, 2017 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | Sep 23, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of treating a disorder characterised by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.